Please wait a minute...
Frontiers of Chemical Science and Engineering

ISSN 2095-0179

ISSN 2095-0187(Online)

CN 11-5981/TQ

Postal Subscription Code 80-969

2018 Impact Factor: 2.809

Front Chem Sci Eng    2011, Vol. 5 Issue (2) : 231-237    https://doi.org/10.1007/s11705-010-1022-7
RESEARCH ARTICLE
Design, synthesis and HIV-RT inhibitory activity of novel thiazolidin-4-one derivatives
Hua CHEN(), Zaihong GUO, Qingmei YIN, Xiaoxu DUAN, Yunjing GU, Xiaoliu LI()
Key Laboratory of Chemical Biology of Hebei Province, College of Chemistry and Environmental Science, Hebei University, Baoding 071002, China
 Download: PDF(204 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

A series of 2-aryl-3-(4,5,6-trimethylpyrimidin-2-yl) thiazolidin-4-ones (1a1c) and their derivatives bearing a lipophilic substituent, like acetoxy group (3a3c), propionyloxy group (4a4c), methyl (5d and 5e) at C-5 on thiazolidin-4-one ring were designed, synthesized and evaluated for their HIV-RT inhibitory activity. Using self-catalyzed Pummerer reaction, compounds 3a3c and 4a4c were obtained in good yield (63.1%75.2%). Preliminary anti-HIV-RT test of these derivatives indicated that compounds 1a1c, 4b (propionyloxy group at C-5) showed moderate HIV-RT inhibitory activity and compounds 5d and 5e with methyl at C-5 showed a weak HIV-RT inhibitory activity. Structure activity relationship analysis suggested that the substituted groups on C-5 would be unfavorable to anti-HIV-RT activity and that the steric effect might play a critical role in the anti-HIV RT activity.

Keywords 5-subsituted thiazolidin-4-ones      Pummerer reaction      anti-HIV-RT activity      SARs     
Corresponding Author(s): CHEN Hua,Email:hua-todd@hbu.cn; LI Xiaoliu,Email:lixl@hbu.cn   
Issue Date: 05 June 2011
 Cite this article:   
Xiaoliu LI,Hua CHEN,Zaihong GUO, et al. Design, synthesis and HIV-RT inhibitory activity of novel thiazolidin-4-one derivatives[J]. Front Chem Sci Eng, 2011, 5(2): 231-237.
 URL:  
https://academic.hep.com.cn/fcse/EN/10.1007/s11705-010-1022-7
https://academic.hep.com.cn/fcse/EN/Y2011/V5/I2/231
Fig.1  2-aryl-3-(4,5,6-trimethylpyrimidin-2-yl) thiazolidin-4-ones and their 5-substiutied derivatives
Fig.2  Synthesis of compounds –, – and – by Pummerer reaction
Reagent and conditions: (a) (1) MW, 140°C in sealed tube, 10 min; (2) MW, 140°C in sealed tube, 2 equiv DCC, 5 min; (b) AcOOH, AcOH, r.t., 5 min; (c) CHCOOH or CHCHCOOH, 100°C, 1?h
Fig.3  Synthesis of compounds and
Reagent and conditions: (a) (1) MW, 140°C in sealed tube, 10 min; (2) MW, 140°C in sealed tube, 2 equiv DCC, 5 min
compoundsRR1R2IC50 (μmol·L-1)
(HIV-RT kit assay)
1aHHH4.66±0.96
1bHH2-Cl2.91±0.24
1cHH4-Cl3.13±1.53
3aOOCCH3HH20.10±2.74
3bOOCCH3H2-Cl72.60±7.18
3cOOCCH3H4-Cl65.83±6.62
4aOOCCH2CH3HH49.73±3.69
4bOOCCH2CH3H2-Cl2.95±0.33
4cOOCCH2CH3H4-Cl>100
5dCH32-Cl6-Cl17.23±4.63
5eCH32-Cl6-F11.86±2.23
3d (control)OOCCH32-Cl6-Cl15.86±1.21 (16.41±2.561))
1d (control) conta)H2-Cl6-Cl0.97±0.06 (Ref. [31] 0.83±0.03)
Tab.1  HIV-RT kit assay for compounds – and –
1 Verma A, Saraf S K. 4-thiazolidinone—a biologically active scaffold. European Journal of Medicinal Chemistry , 2008, 43(5): 897–905
doi: 10.1016/j.ejmech.2007.07.017 pmid:17870209
2 Ramachandran R, Rani M, Kabilan S. Design, synthesis and biological evaluation of novel 2-[(2,4-diaryl-3-azabicyclo[3.3.1]nonan-9-ylidene)hydrazono]-1,3-thiazolidin-4-ones as a new class of antimicrobial agents. Bioorganic & Medicinal Chemistry Letters , 2009, 19(10): 2819–2823
doi: 10.1016/j.bmcl.2009.03.093 pmid:19361987
3 Kamel M M, Ali H I, Anwar M M, Mohamed N A, Soliman A M. Synthesis, antitumor activity and molecular docking study of novel sulfonamide-Schiff’s bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives. European Journal of Medicinal Chemistry , 2010, 45(2): 572–580
doi: 10.1016/j.ejmech.2009.10.044 pmid:19932530
4 Patel N B, Shaikh F M. Synthesis and antimicrobial activity of new 4-thiazolidinone derivatives containing 2-amino-6-methoxybenzothiazole. Saudi Pharmaceutical Journal , 2010, 18: 129–136
5 Amin K M, Kamel M M, Anwar M M, Khedr M, Syam Y M. Synthesis, biological evaluation and molecular docking of novel series of spiro [(2H,3H) quinazoline-2,1′- cyclohexan]-4(1H)- one derivatives as anti-inflammatory and analgesic agents. European Journal of Medicinal Chemistry , 2010, 45(6): 2117–2131
doi: 10.1016/j.ejmech.2009.12.078 pmid:20137837
6 Ronad P M, Noolvi M N, Sapkal S, Dharbhamulla S, Maddi V S. Synthesis and antimicrobial activity of 7-(2-substituted phenylthiazolidinyl)-benzopyran-2-one derivatives. European Journal of Medicinal Chemistry , 2010, 45(1): 85–89
doi: 10.1016/j.ejmech.2009.09.028 pmid:19837487
7 Zhang X Y, Li X Y, Li D F, Qu G R, Wang J J, Loiseau P M, Fan X S. Ionic liquid mediated and promoted eco-friendly preparation of thiazolidinone and pyrimidine nucleoside-thiazolidinone hybrids and their antiparasitic activities. Bioorganic & Medicinal Chemistry Letters , 2009, 19(22): 6280–6283
doi: 10.1016/j.bmcl.2009.09.101 pmid:19819695
8 Abd Alla M S, Hegab M I, Abo Taleb N A, Hasabelnaby S M, Goudah A. Synthesis and anti-inflammatory evaluation of some condensed [4-(3,4-dimethylphenyl)-1(2H)-oxo-phthalazin-2-yl]acetic acid hydrazide. European Journal of Medicinal Chemistry , 2010, 45(4): 1267–1277
pmid:20149488
9 Pan B, Huang R Z, Han S Q, Qu D, Zhu M L, Wei P, Ying H J. Design, synthesis, and antibiofilm activity of 2-arylimino-3-aryl-thiazolidine-4-ones. Bioorganic & Medicinal Chemistry Letters , 2010, 20(8): 2461–2464
doi: 10.1016/j.bmcl.2010.03.013 pmid:20346668
10 Rao A, Balzarini J, Carbone A, Chimirri A, De Clercq E, Monforte A M, Monforte P, Pannecouque C, Zappalà M. 2-(2,6-Dihalophenyl) -3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors. Antiviral Research , 2004, 63(2): 79–84
doi: 10.1016/j.antiviral.2004.03.004 pmid:15302136
11 Rao A, Balzarini J, Carbone A, Chimirri A, De Clercq E, Monforte A M, Monforte P, Pannecouque C, Zappalà M. Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents. II Farmaco , 2004, 59(1): 33–39
doi: 10.1016/j.farmac.2003.09.001 pmid:14751314
12 Barreca M L, Chimirri A, De Clercq E, De Luca L, Monforte A M, Monforte P, Rao A, Zappalà M. Anti-HIV agents: design and discovery of new potent RT inhibitors. Il Farmaco , 2003, 58(3): 259–263
doi: 10.1016/S0014-827X(03)00024-7 pmid:12620421
13 Rao A, Carbone A, Chimirri A, De Clercq E, Monforte A M, Monforte P, Pannecouque C, Zappalà M. Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones. II Farmaco , 2003, 58(2): 115–120
doi: 10.1016/S0014-827X(02)00024-1 pmid:12581777
14 Barreca M L, Balzarini J, Chimirri A, De Clercq E, De Luca L, H?ltje H D, H?ltje M, Monforte A M, Monforte P, Pannecouque C, Rao A, Zappalà M. Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents. Journal of Medicinal Chemistry , 2002, 45(24): 5410–5413
doi: 10.1021/jm020977+ pmid:12431069
15 Rao A, Carbone A, Chimirri A, De Clercq E, Monforte A M, Monforte P, Pannecouque C, Zappalà M. Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-(thi)one derivatives. Il Farmaco , 2002, 57(9): 747–751
doi: 10.1016/S0014-827X(02)01268-5 pmid:12385525
16 Barreca M L, Chimirri A, De Luca L, Monforte A M, Monforte P, Rao A, Zappalà M, Balzarini J, De Clercq E, Pannecouque C, Witvrouw M. Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorganic & Medicinal Chemistry Letters , 2001, 11(13): 1793–1796
doi: 10.1016/S0960-894X(01)00304-3 pmid:11425562
17 Rawal R K, Tripathi R, Katti S B, Pannecouque C, De Clercq E. Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3- thiazolidin-4-ones as anti-HIV agents. Bioorganic & Medicinal Chemistry , 2007, 15(4): 1725–1731
doi: 10.1016/j.bmc.2006.12.003 pmid:17178227
18 Rawal R K, Tripathi R, Katti S B, Pannecouque C, De Clercq E. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents. European Journal of Medicinal Chemistry , 2008, 43(12): 2800–2806
doi: 10.1016/j.ejmech.2007.12.015 pmid:18242784
19 Rawal R K, Tripathi R, Katti S B, Pannecouque C, De Clercq E. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents. Bioorganic & Medicinal Chemistry , 2007, 15(9): 3134–3142
doi: 10.1016/j.bmc.2007.02.044 pmid:17349793
20 Rawal R K, Prabhakar Y S, Katti S B, De Clercq E. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors. Bioorganic & Medicinal Chemistry , 2005, 13(24): 6771–6776
doi: 10.1016/j.bmc.2005.07.063 pmid:16198576
21 Rawal R K, Tripathi R K, Katti S B, Pannecouque C, De Clercq E. Synthesis and biological evaluation of 2,3-diaryl substituted-1,3-thiazolidin-4-ones as anti-HIV agents. Medicinal Chemistry (Shariqah, United Arab Emirates) , 2007, 3(4): 355–363
doi: 10.2174/157340607781024393 pmid:17627572
22 Rawal R K, Tripathi R, Kulkarni S, Paranjape R, Katti S B, Pannecouque C, De Clercq E. 2-(2,6-Dihalo-phenyl)-3-heteroaryl-2-ylmethyl-1, 3-thiazolidin-4-ones: anti-HIV agents. Chemical Biology & Drug Design , 2008, 72(2): 147–154
doi: 10.1111/j.1747-0285.2008.00683.x pmid:18624810
23 Rawal R K, Solomon V R, Prabhakar Y S, Katti S B, De Clercq E. Synthesis and QSAR studies on thiazolidinones as anti-HIV agents. Combinatorial Chemistry & High Throughput Screening , 2005, 8(5): 439–443
doi: 10.2174/1386207054546496 pmid:16101583
24 Prabhakar Y S, Solomon V R, Rawal R K, Gupta M K, Katti S B. CP-MLR/PLS directed structure-activity modeling of the HIV-1 RT inhibitory activity of 2,3-diaryl-1,3-thiazolidin-4-ones. QSAR & Combinatorial Science , 2004, 23(4): 234–244
doi: 10.1002/qsar.200330854
25 Prabhakar Y S, Rawal R K, Gupta M K, Solomon V R, Katti S B. Topological descriptors in modeling the HIV inhibitory activity of 2-aryl-3-pyridyl-thiazolidin-4-ones. Combinatorial Chemistry & High Throughput Screening , 2005, 8(5): 431–437
doi: 10.2174/1386207054546531 pmid:16101582
26 Roy K, Leonard J T. Classical QSAR modeling of anti-HIV 2,3-diaryl-1,3- thiazolidin-4-ones. QSAR & Combinatorial Science , 2005, 24(5): 579–592
doi: 10.1002/qsar.200430901
27 Ravichandran V, Prashantha Kumar B R, Sankar S, Agrawal R K. Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach. European Journal of Medicinal Chemistry , 2009, 44(3): 1180–1187
doi: 10.1016/j.ejmech.2008.05.036 pmid:18687505
28 Murugesan V, Prabhakar Y S, Katti S B. CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents. Journal of Molecular Graphics & Modelling , 2009, 27(6): 735–743
doi: 10.1016/j.jmgm.2008.11.006 pmid:19117780
29 Balzarini J, Orzeszko-Krzesińska B, Maurin J K, Orzeszko A. Synthesis and anti-HIV studies of 2- and 3-adamantyl-substituted thiazolidin-4-ones. European Journal of Medicinal Chemistry , 2009, 44(1): 303–311
doi: 10.1016/j.ejmech.2008.02.039 pmid:18420310
30 Balzarini J, Orzeszko B, Maurin J K, Orzeszko A. Synthesis and anti-HIV studies of 2-adamantyl-substituted thiazolidin-4-ones. European Journal of Medicinal Chemistry , 2007, 42(7): 993–1003
doi: 10.1016/j.ejmech.2007.01.003 pmid:17321639
31 Chen H, Bai J, Jiao L L, Guo Z H, Yin Q M, Li X L. Design, microwave-assisted synthesis and HIV-RT inhibitory activity of 2-(2,6-dihalophenyl)-3-(4,6-dimethyl-5-(un)substituted-pyrimidin-2-yl)thiazolidin-4-ones. Bioorganic & Medicinal Chemistry , 2009, 17(11): 3980–3986
doi: 10.1016/j.bmc.2009.04.024 pmid:19411176
32 Colombo A, Fernàndez J C, Fernández-Forner D, dela Figuera N, Albericio F, Forns P. Stereomeric studies on the oxidation and alkylation of 4-thiazolidinones. Tetrahedron Letters , 2008, 49(10): 1569–1572
doi: 10.1016/j.tetlet.2008.01.038
33 Colombo A, Albericio F, Forns P. Sulfoxidations in the solid phase. Tetrahedron, Asymmetry , 2006, 17(24): 3327–3331
doi: 10.1016/j.tetasy.2006.12.014
34 Arey B J, Yanofsky S D, Claudia Pérez M, Holmes C P, Wrobel J, Gopalsamy A, Stevis P E, López F J, Winneker R C. Differing pharmacological activities of thiazolidinone analogs at the FSH receptor. Biochemical and Biophysical Research Communications , 2008, 368(3): 723–728
doi: 10.1016/j.bbrc.2008.01.119 pmid:18252197
35 Wrobel J, Jetter J, Kao W, Rogers J, Di L, Chi J, Peréz M C, Chen G C, Shen E S. 5-Alkylated thiazolidinones as follicle-stimulating hormone (FSH) receptor agonists. Bioorganic & Medicinal Chemistry , 2006, 14(16): 5729–5741
doi: 10.1016/j.bmc.2006.04.012 pmid:16675221
36 De Lucchi O, Miotti U, Midena G. The Pummerer reaction of sulfinyl compounds. Organic Reactions , 1991, 40: 158–188
37 Kürti L, Czakó B. Strategic Applications of Named Reactions in Organic Synthesis. Beijing: Science Publication, 2007, 368
38 Reverse Transcriptase Assay, Colorimetric kit, Roche Diagnostics GmbH. Roche Applied Science, Sandhofer Strasse 116, D-68305 Mannheim, Germany
39 Rao A, Chimirri A, Ferro S, Monforte A M, Monforte P, Pannecouque C, Zappalà M. Microwave-induced synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors. ARKIVOC , 2004: 147–155
40 Bolognese A, Correale G, Manfra M, Lavecchia A, Novellino E, Barone V. Thiazolidin-4-one formation. Mechanistic and synthetic aspects of the reaction of imines and mercaptoacetic acid under microwave and conventional heating. Organic & Biomolecular Chemistry , 2004, 2(19): 2809–2813
doi: 10.1039/b405400h pmid:15455154
41 Srivastava T, Haq W, Katti S B. Carbodiimide mediated synthesis of 4-thiazolidinones by one-pot three-component condensation. Tetrahedron , 2002, 58(38): 7619–7624
doi: 10.1016/S0040-4020(02)00866-9
42 Gududuru V, Nguyen V, Dalton J T, Miller D D. Efficient microwave enhanced synthesis of 4-thiazolidinones. Synlett , 2004, 13: 2357–2358
43 Fraga-Dubreuil J, Bazureau J P. Efficient combination of task-specific ionic liquid and microwave dielectric heating applied to one-pot three component synthesis of a small library of 4-thiazolidinones. Tetrahedron , 2003, 59(32): 6121–6130
doi: 10.1016/S0040-4020(03)00954-2
44 Dandia A, Singh R, Khaturia S, Mérienne C, Morgant G, Loupy A. Efficient microwave enhanced regioselective synthesis of a series of benzimidazolyl/triazolyl spiro [indole-thiazolidinones] as potent antifungal agents and crystal structure of spiro[3H-indole-3,2'-thiazolidine]-3'(1,2,4-triazol-3-yl)-2,4'(1H)-dione. Bioorganic & Medicinal Chemistry , 2006, 14(7): 2409–2417
doi: 10.1016/j.bmc.2005.11.025 pmid:16321543
45 Sriram D, Yogeeswari P, Kumar T G A. Microwave-assisted synthesis and anti-YFV activity of 2,3-diaryl-1,3-thiazolidin-4-ones. Journal of Pharmacy & Pharmaceutical Sciences , 2005, 8(3): 426–429
pmid:16401393
46 Yadav A K, Kumar M, Yadav T, Jain R. An ionic liquid mediated one-pot synthesis of substituted thiazolidinones and benzimidazoles. Tetrahedron Letters , 2009, 50(35): 5031–5034
doi: 10.1016/j.tetlet.2009.06.091
47 Mali J R, Pratap U R, Netankar P D, Mane R A. An efficient synthetic route for quinazolinyl 4-thiazolidinones. Tetrahedron Letters , 2009, 50(35): 5025–5027
doi: 10.1016/j.tetlet.2009.06.086
48 Chen H, Bai J, Zhao L, Yuan X G, Li X L, Cao K Q. Microwave assisted synthesis and antibacterial study of 3-naphthyl-2-[(un)substituted phenyl]-1,3-thiazolidin-4-ones. Chin J Org Chem , 2008, 28: 1092–1096 (in Chinese)
49 Chen H, Bai J, Zhao L, Yuan X G, Li X L, Cao K Q. Microwave assisted synthesis and antifungal, anti-tumor study of 2-(2,6-Dichlorophenyl)-1,3-thiazolidin-4-ones. Chin J Org Chem , 2009, 29: 94–99 (in Chinese)
50 Mamaghani M, Loghmanifar A, Taati M R. An efficient one-pot synthesis of new 2-imino-1,3-thiazolidin-4-ones under ultrasonic conditions. Ultrasonics Sonochemistry , 2011, 18(1): 45–48
doi: 10.1016/j.ultsonch.2010.05.009 pmid:20579925
51 Neuenfeldt P D, Drawanz B B, Siqueira G M, Gomes C R B, Wardell S M S V, Flores A F C, Cunico W. Efficient solvent-free synthesis of thiazolidin-4-ones from phenylhydrazine and 2,4-dinitrophenylhydrazine. Tetrahedron Letters , 2010, 51(23): 3106–3108
doi: 10.1016/j.tetlet.2010.04.026
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed